---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-171970"
form_type: "8-K"
ticker: "GRTX"
cik: "0001563577"
company_name: "Galera Therapeutics, Inc."
filed_at: "2022-06-10T23:59:59+00:00"
generated_at: "2026-06-25T02:44:36.729624+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Galera Therapeutics receives Nasdaq delisting notice for failure to meet $50M MVLS requirement

## Summary
- Received Nasdaq notice on June 8, 2022 for non-compliance with minimum Market Value of Listed Securities of $50M.
- Has 180 days, until December 5, 2022, to regain compliance by closing at $50M+ for 10 consecutive business days.
- Stock continues trading on Nasdaq Global Market under symbol GRTX; may consider transfer to Nasdaq Capital Market.
- No assurance of regaining compliance; failure may lead to delisting subject to appeal.

## SEC filing metadata
- accession: 0001193125-22-171970
- form_type: 8-K
- ticker: GRTX
- cik: 0001563577
- company_name: Galera Therapeutics, Inc.
- filed_at: 2022-06-10T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563577/000119312522171970/0001193125-22-171970-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563577/000119312522171970/d368942d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-171970
- JSON: https://secwatch.observer/filing/0001193125-22-171970.json
- Plain text: https://secwatch.observer/filing/0001193125-22-171970.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.